Small Cap Stocks To Follow Today – January 4th

04 Jan 2026, 15:04 by Renee Jackson · The Cerbat Gem

Sidus Space, Spring Valley Acquisition, Direxion Daily PLTR Bear 1X Shares, Brand Engagement Network, and Ironwood Pharmaceuticals are the five Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small-cap stocks are shares of companies with relatively small market capitalizations, typically in the roughly $300 million to $2 billion range (definitions vary by index or data provider). They often offer higher growth potential but also greater volatility and risk than large-cap stocks because these companies are less established, have lower liquidity, and are more sensitive to economic changes. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Sidus Space (SIDU)

Sidus Space, Inc., a space-as-a-service company, engages in the design, manufacture, launch, and data collection of commercial satellite worldwide. Its space services include satellite/space hardware manufacturing; Low Earth Orbit (LEO) launch and deployment services; and space-based geospatial intel, imagery, and data analytics.

Read Our Latest Research Report on SIDU

Spring Valley Acquisition (SV)

Read Our Latest Research Report on SV

Direxion Daily PLTR Bear 1X Shares (PLTD)

Read Our Latest Research Report on PLTD

Brand Engagement Network (BNAI)

Brand Engagement Network, Inc. provides conversational AI assistants. The company offers security-focused, multimodal communication, and human-like assistants. Its AI assistants are built on proprietary natural language processing, anomaly detection, multisensory awareness, sentiment, and environmental analysis, as well as real-time individuation and personalization capabilities.

Read Our Latest Research Report on BNAI

Ironwood Pharmaceuticals (IRWD)

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States, Mexico, Japan, Saudi Arabia, and China, as well as under the CONSTELLA name in the Canada and European countries.